Search results for "Comparative"

showing 10 items of 1371 documents

OHADA et COMMON LAW : amis ou ennemis?

2012

The article examines the oHADA law in a comparative perspective, trying to individuate how it can be considered from a common law perspective.

OHADA common law civil law comparative law
researchProduct

The EU’s online gambling regulatory approach and the crisis of legal modernity

2014

ONLINE GAMBLING EU LAW COMPARATIVE LAW INTERNATIONAL CONTRACTS
researchProduct

Mammary olfactory signalisation in females and odor processing in neonates: ways evolved by rabbits and humans

2009

International audience; Mammalian females have long been known to release olfactory attraction in their offspring. Mammary odor cues control infant state, attention and directional responses, delay distress responses, stimulate breathing and positive oral actions, and finally can boost learning. Here, we survey female-offspring odor communication in two mammalian species - European rabbits and humans - taken as representatives of evolutionary extremes in terms of structure and dynamics of mother-infant relations, and level of neonatal autonomy. Despite these early psychobiological differences, females in both species have evolved mammary structures combining multiple sources of endogenous a…

OffspringPheromones HumanContext (language use)Sensory systemOlfactionBiologyPheromones03 medical and health sciencesBehavioral Neurosciencepheromone0302 clinical medicineSpecies Specificityrabbit (Oryctolagus cuniculus)AnimalsHumans0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyhumanMaternal BehaviorComputingMilieux_MISCELLANEOUSInstinctCommunicationmilkbusiness.industryMechanism (biology)[SCCO.NEUR]Cognitive science/Neuroscience05 social sciencesOlfactory PathwaysBiological EvolutionAnimals SucklingBreast FeedingOdorAnimals NewbornOdorantsmother-infant relations[ SCCO.NEUR ] Cognitive science/NeurosciencePheromonePerceptionRabbitsneonatebusinessNeuroscienceBreast feeding030217 neurology & neurosurgeryolfaction
researchProduct

Use of ultrasonic vocalizations to assess olfactory detection in mouse pups treated with 3-methylindole.

2005

International audience; Altricial mammals use olfaction long before the olfactory bulb has reached its anatomically mature state. Indeed, while audition and vision are still not functional, the olfactory system of newborn animals can clearly process distinct odorant molecules. Although several previous studies have emphasized the important role that olfaction plays in early critical functions, it has been difficult to develop a sensitive and reliable test to precisely quantify olfactory ability in pups. One difficulty in determining early sensory capabilities is the rather limited behavioral repertory of neonates. The present study examines the use of ultrasonic vocalizations emitted by iso…

Olfactory systemMale[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyMESH: UltrasonicsMESH : Behavior AnimalMESH: Animals NewbornBehavioral NeuroscienceMice0302 clinical medicineDiscrimination PsychologicalUltrasound emissionMESH: SmellMESH: Behavior AnimalUltrasonicsMESH: AnimalsMESH: Discrimination (Psychology)OlfactotoxinBehavior AnimalMESH : Animals Newborn05 social sciencesGeneral MedicineMESH : OdorsSkatoleSmellAltricialmedicine.anatomical_structure[ SDV.NEU.NB ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]MESH : UltrasonicsMESH : Sensory DeprivationMESH : MaleMESH: Vocalization AnimalMESH: SkatoleSensory systemMESH : Mice Inbred C57BLOlfactionBiologyDevelopment03 medical and health sciencesMESH: Mice Inbred C57BLMESH : MicemedicineAnimals0501 psychology and cognitive sciencesSensory deprivation050102 behavioral science & comparative psychologyMESH: MiceBehaviorMESH: Sensory DeprivationMESH: OdorsMESH : Vocalization AnimalMESH : SkatoleMESH : Discrimination (Psychology)OlfactionMESH: MaleOlfactory bulbMice Inbred C57BLOdorAnimals NewbornOdorantsMESH : SmellAnimal Science and ZoologyMESH : AnimalsSensory DeprivationVocalization AnimalOlfactory epitheliumNeuroscience030217 neurology & neurosurgery
researchProduct

Cost uncertainty and trade liberalization in international oligopoly

1998

Abstract Trade liberalization has been shown to be unfavourable for firms of at least one country for the homogeneous goods case in an environment of certainty. We show that, in the presence of private cost information and for ex ante identical firms, oligopolistic firms will prefer to operate under free trade rather than under autarky in homogeneous goods industries provided there exists a certain degree of firms' heterogeneity and a sufficiently large amount of uncertainty. For the particular case of symmetry both in demand and industry sizes, the firms of at least one country prefer to operate under autarky rather than under free trade.

OligopolyMicroeconomicsEconomics and EconometricsEx-anteHomogeneousEconomicsMonetary economicsAutarkyTrade barrierFree tradeFinanceComparative advantageJournal of International Economics
researchProduct

Frequent chromosomal gains in recurrent juvenile nasopharyngeal angiofibroma.

2007

Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor, mostly affecting adolescent males. Some patients develop recurrences after surgery independently of completeness of removal. Only very limited data concerning underlying chromosomal changes are available. We therefore analyzed samples of 22 JNAs, including six recurrences, with comparative genomic hybridization (CGH). Additionally, quantitative image cytometry was used for measurement of DNA aneuploidy in representative samples. Of the 13 primary JNAs without later recurrence, DNA gains were identified on autosomes in only two samples. Four patients with one or two recurrences were included in the study; for one of these, no…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyAdolescentJuvenile nasopharyngeal angiofibromaBiologyBioinformaticsAngiofibromaBenign tumorInternal medicineGeneticsmedicineHumansChildMolecular BiologyGeneChromosome AberrationsAutosomeNucleic Acid HybridizationNasopharyngeal NeoplasmsGenomicsDna amplificationmedicine.diseasePrimary tumorChromosome 4Neoplasm Recurrence LocalComparative genomic hybridizationCancer genetics and cytogenetics
researchProduct

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing live…

2010

Abstract Background The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) have been performed to demonstrate anti-neoplastic effects in the pure oncology setting, and at present, no oncology endpoint-directed RCT has been reported in the high-malignancy risk population of immunosuppressed transplant recipients. Interestingly, since mTOR inhibitors have both immunosuppressive and anti-cancer effects, they have the potential to simultaneously protect against immunologic graft loss and tumour development. Therefore, we designed a prospective RCT to determine if the mTOR inhibito…

OncologyCancer ResearchTime Factorsmedicine.medical_treatmentMedizinIntracellular Signaling Peptides and Proteins - antagonists & inhibitors metabolismKaplan-Meier Estimate312 Clinical medicineProtein-Serine-Threonine KinaseLiver transplantationTHERAPYStudy ProtocolImmunosuppressive Agentendothelial growth-factor renal-cell carcinoma tumor progression rapamycin cancer cyclosporine efficacy therapy target model0302 clinical medicineRENAL-CELL CARCINOMARisk FactorsRecurrenceSurgical oncologyMedicine and Health SciencesLiver Neoplasms - drug therapy enzymology mortality surgerySirolimuProspective StudiesTUMOR PROGRESSIONTransplantation Homologoueducation.field_of_studyliver transplantationTOR Serine-Threonine KinasesLiver NeoplasmsIntracellular Signaling Peptides and ProteinsImmunosuppressionhepatocellular carcinomalcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCANCER3. Good healthEuropeMulticenter StudyTreatment OutcomeTARGETsirolimusOncologyLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaRandomized Controlled TrialmTORCarcinoma Hepatocellular - drug therapy enzymology mortality surgery030211 gastroenterology & hepatologyImmunosuppressive AgentsRCTHumanmedicine.drugCanadamedicine.medical_specialtyCarcinoma HepatocellularTime FactoreducationPopulationLiver Transplantation - adverse effects mortalityProtein Serine-Threonine Kinaseslcsh:RC254-282Disease-Free Survival03 medical and health sciencesInternal medicineGeneticsmedicineTransplantation HomologousHumansComparative StudyRapamycinddc:610educationProtein-Serine-Threonine Kinases - antagonists & inhibitors metabolismKaplan-Meiers Estimatebusiness.industryRisk FactorAustraliaImmunosuppressive Agents - therapeutic useSirolimus - therapeutic useEFFICACYHumans; Liver Transplantation; Hepatocellular Carcinoma; Randomized Controlled Trial; RCT; Multicenter Study; Comparative Study; Rapamycin; mTOR; Sirolimusmedicine.diseaseSurgeryMODELTransplantationClinical trialProspective StudieIntracellular Signaling Peptides and ProteinSirolimusENDOTHELIAL GROWTH-FACTORCYCLOSPORINERAPAMYCINbusiness
researchProduct

Perfil genómico del neuroblastoma de alto riesgo mediante hibridación genómica comparada

2006

El neuroblastoma presenta alteraciones genéticas que predicen su evolución clínica. Ganancias cromosómicas completas están asociadas a estadios clínicos no avanzados y evolución favorable, mientras que pérdidas de 1p, ganancia de 17q y amplificación del gen MYCN (MNA) son indicativas de estadios clínicos avanzados y pronóstico desfavorable. Son neuroblastomas de alto riesgo (NB-HR) los presentes en niños mayores de un año: estadio 4 o MNA en cualquier estadio de enfermedad, excluyendo estadio 1. El pronóstico de estos enfermos es malo, incluso con tratamientos agresivos. Sólo MNA confiere valor pronóstico negativo. Se remitieron al Centro de Referencia Nacional del neuroblastoma 60 casos de…

OncologyComparative genomic hybridizationmedicine.medical_specialtyBiological studiesmedicine.diagnostic_testbusiness.industryFluorescence in situ hybridizationClinical courseIn situ hybridizationmedicine.diseasePediatricsRJ1-570NeuroblastomaInternal medicineNeuroblastomaMYCNPediatrics Perinatology and Child Healthmedicine1p DeletionStage (cooking)businessFluorescence in situ hybridizationComparative genomic hybridizationAnales de Pediatría
researchProduct

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy includi…

2015

Part of this study has been reported as an oral presentation at the EHA Meeting in Vienna 2015.

OncologyMalemedicine.medical_treatmentarray-based comparative genomic hybridization (aCGH)Intensive chemotherapyKaplan-Meier EstimateBioinformatics0302 clinical medicinerituximabAntineoplastic Combined Chemotherapy ProtocolsYoung adultComparative Genomic HybridizationGenomeArray-based comparative genomic hybridizationBurkitt lymphomaHigh-Throughput Nucleotide SequencingHematologyMiddle AgedPrognosisBurkitt Lymphomahumanities3. Good healthTreatment Outcome030220 oncology & carcinogenesisoutcomeRituximabFemaleRituximabmedicine.drugAdultmedicine.medical_specialtyAdolescenteducationBiologyNext-generation sequencing outcome03 medical and health sciencesYoung AdultInternal medicinemedicineHumansIn patientAgedChromosome AberrationsChemotherapymedicine.diseaseGNA13Lymphomastomatognathic diseasesnext-generation sequencing030215 immunologyComparative genomic hybridization
researchProduct

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

2013

Estrogen receptor (ER)-negative tumors represent 20-30% of all breast cancers, with a higher proportion occurring in younger women and women of African ancestry. The etiology and clinical behavior of ER-negative tumors are different from those of tumors expressing ER (ER positive), including differences in genetic predisposition. To identify susceptibility loci specific to ER-negative disease, we combined in a metaanalysis 3 genome-wide association studies of 4,193 ER-negative breast cancer cases and 35,194 controls with a series of 40 follow-up studies (6,514 cases and 41,455 controls), genotyped using a custom Illumina array, iCOGS, developed by the Collaborative Oncological Gene-environm…

Oncologygenetic associationbody-mass indexEstrogen receptorGenome-wide association studycancer riskBioinformaticssusceptibilitychromosome 1q0302 clinical medicineRisk Factorssingle nucleotide polymorphismGenotypeestrogenCooperative Behaviorcomparative studyOligonucleotide Array Sequence Analysis0303 health scienceschromosome 16q3. Good healthReceptors Estrogenpriority journal030220 oncology & carcinogenesisFemalecancer invasionsignal transductionbreast cancer; cancer invasion; cancer risk; chromosome 1; chromosome 16q; chromosome 1q; chromosome 2p; comparative study; follow up; gene locus; genetic association; genetic susceptibility; human; nucleotide sequence; priority journal; signal transduction; single nucleotide polymorphismmedicine.medical_specialtyGenotypegene locusBreast NeoplasmsSingle-nucleotide polymorphismBiologyPolymorphism Single NucleotideArticle03 medical and health sciencesBreast cancerbreast cancerMeta-Analysis as TopicSDG 3 - Good Health and Well-beingInternal medicineexpressionGeneticsmedicineGenetic predispositionHumansfollow upGenetic Predisposition to Diseasehumanchromosome 1gene030304 developmental biologyCase-control studyCancernucleotide sequencemedicine.diseasechromosome 2pGenetic LociCase-Control Studiescommon variantGenome-Wide Association Studygenetic susceptibilityNature Genetics
researchProduct